Overview
Parker Institute for Cancer Immunotherapy is an early-stage venture capital firm headquartered in the United States, focused on seed-, startup- and growth-stage startups.
Connected profiles
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
总部位于美国的Parker Institute for Cancer Immunotherapy，是一家早期风险投资机构，专注种子期、初创期到成长期创业公司。